clinical trial · NCT07176117
Surfactant Using a Supraglottic Airway Device in Late Preterm to Early Term Infants
Sharp HealthCare·N/A·not yet recruiting·n = 422
Respiratory Distress Syndrome (Neonatal)SurfactantSurfactant Administration Through Laryngeal or Supraglottic Airway (SALSA)Continuous Positive Airway Pressure (CPAP)
brief summary
The purpose of this research is to learn new information that may help other infants that have respiratory distress syndrome and need breathing support after birth. The goal of this research is to see if continuous positive airway pressure (CPAP) alone or CPAP with surfactant administration through a less invasive method via an Airway Device (supraglottic airway device) temporarily placed above the vocal cords is better for treating respiratory distress syndrome in late preterm and early term infants.
started
Oct 1, 2025
primary completion
Dec 31, 2030
completion
Jun 30, 2031
last updated
Sep 16, 2025
official title
Surfactant Prophylaxis in LAte Preterm to Early Term Infants Using a Supraglottic Airway Device to Help Improve Outcomes
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol